| Literature DB >> 21521747 |
Seth J Salpeter1, Agnes Klochendler, Noa Weinberg-Corem, Shay Porat, Zvi Granot, A M James Shapiro, Mark A Magnuson, Amir Eden, Joseph Grimsby, Benjamin Glaser, Yuval Dor.
Abstract
Understanding the molecular triggers of pancreatic β-cell proliferation may facilitate the development of regenerative therapies for diabetes. Genetic studies have demonstrated an important role for cyclin D2 in β-cell proliferation and mass homeostasis, but its specific function in β-cell division and mechanism of regulation remain unclear. Here, we report that cyclin D2 is present at high levels in the nucleus of quiescent β-cells in vivo. The major regulator of cyclin D2 expression is glucose, acting via glycolysis and calcium channels in the β-cell to control cyclin D2 mRNA levels. Furthermore, cyclin D2 mRNA is down-regulated during S-G(2)-M phases of each β-cell division, via a mechanism that is also affected by glucose metabolism. Thus, glucose metabolism maintains high levels of nuclear cyclin D2 in quiescent β-cells and modulates the down-regulation of cyclin D2 in replicating β-cells. These data challenge the standard model for regulation of cyclin D2 during the cell division cycle and suggest cyclin D2 as a molecular link between glucose levels and β-cell replication.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21521747 PMCID: PMC3115606 DOI: 10.1210/en.2010-1372
Source DB: PubMed Journal: Endocrinology ISSN: 0013-7227 Impact factor: 4.736